The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data

Saved in:
Bibliographic Details
Published in:Leukemia research 2020-10, Vol.97, p.106429-106429, Article 106429
Main Authors: Avivi, Irit, Gatt, Moshe E., Luttwak, Efrat, Magen, Hila, Dally, Najib, Cohen, Yael C., Benyamini, Noam, Lavi, Noa
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Antibiotic Prophylaxis - methods
Antibiotic Prophylaxis - mortality
Antineoplastic Agents - therapeutic use
Bridged Bicyclo Compounds, Heterocyclic - therapeutic use
Drug Resistance, Neoplasm - drug effects
Female
Follow-Up Studies
Humans
Levofloxacin prophylaxis
Male
Middle Aged
Neoplasm Recurrence, Local - drug therapy
Neoplasm Recurrence, Local - mortality
Neoplasm Recurrence, Local - pathology
Paraproteinemias - drug therapy
Paraproteinemias - mortality
Paraproteinemias - pathology
Prognosis
relapsed/refractory multiple myeloma
Retrospective Studies
Salvage Therapy
Sulfonamides - therapeutic use
Survival Rate
t(11
14)
Venetoclax
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0145-2126
1873-5835
DOI:10.1016/j.leukres.2020.106429